Država: Švedska
Jezik: švedski
Izvor: Läkemedelsverket (Medical Products Agency)
metotrexat
Alfrapharma s.r.l.
L04AX03
methotrexate
15 mg
Injektionsvätska, lösning i förfylld injektionspenna
metotrexat 15 mg Aktiv substans
Receptbelagt
Förpacknings: Förfylld penna, 2 st (15 mg/0,3 ml); Förfylld penna, 4 st (15 mg/0,3 ml); Förfylld penna, 5 st (15 mg/0,3 ml); Förfylld penna, 6 st (15 mg/0,3 ml); Förfylld penna, 10 st (15 mg/0,3 ml); Förfylld penna, 11 st (15 mg/0,3 ml); Förfylld penna, 12 st (15 mg/0,3 ml); Förfylld penna, 14 st (15 mg/0,3 ml); Förfylld penna, 15 st (15 mg/0,3 ml); Förfylld penna, 24 st (15 mg/0,3 ml); Förfylld penna, 1 st (15 mg/0,3 ml)
Avregistrerad
2019-08-16
PACKAGE LEAFLET: INFORMATION FOR THE USER MERAVO 7.5 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN MERAVO10 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN MERAVO 12.5 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN MERAVO 15 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN MERAVO 17.5 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN MERAVO 20 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN MERAVO 22.5 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN MERAVO 25 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN methotrexate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Meravo is and what it is used for 2. What you need to know before you use Meravo 3. How to use Meravo 4. Possible side effects 5. How to store Meravo 6. Contents of the pack and other information 1. WHAT MERAVO IS AND WHAT IT IS USED FOR Meravo is indicated for the treatment of: active rheumatoid arthritis in adult patients. polyarthritic forms of severe, active juvenile idiopathic arthritis, when the response to nonsteroidal anti-inflammatory drugs (NSAIDs) has been inadequate. moderate to severe psoriasis in adult patients, and severe psoriatic arthritis in adults. mild to moderate Crohn’s disease in adult patients when adequate treatment with other medicines is not possible. RHEUMATOID ARTHRITIS (RA) is a chronic disease, characterised by inflammation of the synovial membranes (joint membranes). These membranes produce a fluid which acts as a lubricant for many joints. The inflammation causes thickening of the membrane and swelling of th Pročitajte cijeli dokument
MARKNADSFÖRS EJ FÖR NÄRVARANDE. _Produktinformation_ Pročitajte cijeli dokument